Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 150, pseudogene (RN7SL150P)** is a human pseudogene related to the 7SL RNA family. Pseudogenes like RN7SL150P are considered non-functional genomic elements that arise primarily through the reverse transcription and integration of their parental RNA gene back into the genome, but they do not produce functional products[1][4][8]. The parental 7SL RNA is the RNA component of the signal recognition particle, a ribonucleoprotein complex essential for cotranslational targeting of secretory proteins to the endoplasmic reticulum[5]. However, the RN7SL150P pseudogene itself is generally regarded as inactive, does not encode a functional protein or RNA, is not associated with therapeutic targeting, and currently lacks evidence of involvement in biological functions, disease, or pharmacological interaction[1][4][8]. **Context and notes:** - RN7SL150P is a pseudogene, not a protein-coding or regulatory gene[1]. - The gene is not known to be expressed nor implicated as a disease biomarker, drug target, or a participant in molecular pathways[1][4][8]. - Most human 7SL RNA-like sequences are pseudogenes; only a few code functional RNAs[4][8]. - As a pseudogene, it shares sequence similarity with functional 7SL RNA but does not contribute directly to signal recognition particle function or related biology[4][5]. This target is **not considered a therapeutic target**, is likely nonfunctional, and is included in human genomic annotations primarily for completeness and evolutionary studies[1][4][8]. If this result was requested for drug discovery or molecular targeting, it is most likely not relevant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 150, pseudogene (RN7SL150P).